Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Both ASR I and ASR II are effective scalp reduction techniques, with ASR I creating finer scars and ASR II removing more bald area and reducing stretch-back.

Androgenic alopecia (AA) in Indian women is rarely reported, with varying severity and patterns, and hair pull tests and trichograms help understand it better.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Certain genes are linked to the risk of developing Alopecia Areata.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Thai plant extracts, especially Avicennia marina, can promote hair growth by inhibiting certain enzymes and boosting growth factors.

5-ARI therapy may help prevent prostate cancer progression.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

JAK inhibitors might help treat alopecia areata.

Tattoos may trigger autoimmune symptoms in some people.

IGF-1R may play a role in female hair loss and could be a treatment target.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Alopecia Areata might be linked to Crohn's disease.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The compounding pharmacy in Venâncio Aires generally follows good practices, with only the Paracetamol sample showing significant microbial growth.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

IL-15 promotes hair growth and protects hair follicles.